Alan S. Gamis

The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions

Hamid Bolouri, Jason E. Farrar, Timothy J. Triche et al. · Nature Medicine · 2017 · 875 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Gemtuzumab Ozogamicin in Children and Adolescents With De Novo Acute Myeloid Leukemia Improves Event-Free Survival by Reducing Relapse Risk: Results From the Randomized Phase III Children's Oncology Group Trial AAML0531

Alan S. Gamis, Todd A. Alonzo, Soheil Meshinchi et al. · Journal of Clinical Oncology · 2014 · 472 citations · Full text

Medicine, Oncology, Pediatrics +17

Residual disease detected by multidimensional flow cytometry signifies high relapse risk in patients with de novo acute myeloid leukemia: a report from Children's Oncology Group

Michael R. Loken, Todd A. Alonzo, Laura Pardo et al. · Blood · 2012 · 293 citations · Full text

Medicine, Hematology, Oncology +17

Mutagenesis of GATA1 is an initiating event in Down syndrome leukemogenesis

Gina Mundschau, Sandeep Gurbuxani, Alan S. Gamis et al. · Blood · 2003 · 237 citations · Full text

Life Sciences, Genetics, Molecular Genetics +10

Natural history of transient myeloproliferative disorder clinically diagnosed in Down syndrome neonates: a report from the Children's Oncology Group Study A2971

Alan S. Gamis, Todd A. Alonzo, Robert B. Gerbing et al. · Blood · 2011 · 230 citations · Full text

Medicine, Hematology, Pediatrics +9